Intra-aortic balloon counterpulsation (IABC) is a valuable and accepted method of augmenting the failing heart when the cause is potentially reversible. The intra-aortic balloon (lAB) is usually inserted via the femoral artery and placed in the descending thoracic aorta just distal to the left subclavian artery. Inflation of the lAB during diastole increases mean diastolic blood pressure and augments coronary artery diastolic blood flow. Deflation of the IAB in systole decreases left ventricular afterload and consequently myocardial oxygen consumption.~ Indications for IABC include unstable angina, reversable mechanical cardiac defects (acute mitral regurgitation and ventricular septal defect), pro-coronary artery by-pass stabilization, weaning from cardiopulmonary bypass (CPB) and cardiogenic shock." This is a report of an unusual complication of IABC in the weaning of a patient from cardiopulraonary bypass
Rupture of an intra-aortic ballon (IAB), inserted to assist in weaning from cardiopulmonary bypass, occurred during attempted intra-aortic administration of protamine in a 71-yearold male who later died. lntra-aortic balloon c~unterpulsation (IABC) is most commonly utilized to assist in weaning from cardiopulmonary bypass (CPB) or to augment low-flow states following CPB. In-hospital survival following lAB insertion in these circumstances in patients wtth coronary artery disease is approximately 60 per cent, Patients with valvular disease have a lower in-ho.~pitat survival rate (50 per cent). Complications of IABC are usually of vascular or infectious origin. Balloon ruptnre is a rare though potentially lethal compFication. The effects of balloon rapture may be compounded by the use of helium as a driving gas to inflate the balloon, hztra-aortic administration of protamine has not been shown to be superior to peripheral administration and should be avoided if an lAB is in place.
Intra-aortic balloon counterpulsation (IABC) is a valuable and accepted method of augmenting the failing heart when the cause is potentially reversible. The intra-aortic balloon (lAB) is usually inserted via the femoral artery and placed in the descending thoracic aorta just distal to the left subclavian artery. Inflation of the lAB during diastole increases mean diastolic blood pressure and augments coronary artery diastolic blood flow. Deflation of the IAB in systole decreases left ventricular afterload and consequently myocardial oxygen consumption.~ Indications for IABC include unstable angina, reversable mechanical cardiac defects (acute mitral regurgitation and ventricular septal defect), pro-coronary artery by-pass stabilization, weaning from cardiopulmonary bypass (CPB) and cardiogenic shock." This is a report of an unusual complication of IABC in the weaning of a patient from cardiopulraonary bypass A 71-year-old, 75kg, 156cm male presented with unstable angina for coronary artery bypass grafting, He gave a history of increasing incidence of anterior chest pain in the three months prior to admission which was resistant to medical therapy. Eight years previously he had an inferior wall myocardial infarction from which he had recovered without incident. The past history was otherwise unremarkable. Coronary angiography confirmed the presence of severe eoronary disease with a 90 per cent occlusion of the LAD, a 95 per cent occlusion of the RCA and a 40 per cent occlusion of the left main coronary artery. Posterior and basal hypokinesis was noted.
The patient arrived in the operating room pain-free and arterial and pulmonary artery monitorLng lines were inserted without difficulty. Base line haemodynamic data obtained prior to induction of anaesthesia revealed a low cardiac index with a normal systemic vascular resistance. Anaesthesia was induced with sufentanil (20 v,g' kg -I) supplemented by diazepam (50 lag' kg-~). A combination of metocurine and pancuronium was used to provide muscle relaxation.
The patient underwent triple coronary artery revascularization uneventfully. Difficulty, however, was experienced in weaning from CPB, due to severe right ventricular dysfunction, as evidenced by a markedly hypokinetic right ventricle and elevated right heart filling pressures (CVP 18 mmHg). A second weaning attempt after a period of rest on CPB was initially successful, but despite infusions of both dopamine (15 i.tg. kg-i. min-i) and dobutamine, 15 v-g" kg-~ -min -~, adequate circulation could not be maintained. CPB was reinstituted and a Kontmn 9.5 F IAB was inserted percutaneously via the right common femoral artery and connected to a Kontron K2000 pump using helium as the driving gas. The IAB was thought to be positioned in the descending thoracic aorta, distal to the origin of the left subclavian artery. The insertion length of the IAB was estimated by measuring the distance between the clavicle and the femoral artery. There was insufficient time for radiologieal eonfomlation of its position. With the assistance of IABC and continued administration of dopamine and dobutamine, the patient was successfully weaned from CPB. After a 20-minute period of low-normal but stable haemodynamic parameters the venous eannula was removed. Two attempts were made to administer protamine directly into the ascending aorta using a 60 ml syringe containing the appropriate dose of protamine, connected to a 1.5 inch 22 gauge needle, but on both occasions a bubble was noted in the fluid after the needle had been inserted into the aorta. Intra-aortic protamine administration was abandoned and the syringe was passed to the anaesthetist for intravenous administration.
At this time a gas bubble was noted in the aortic peffusion tubing. Seconds later several more bubbles were noted and the patient's blood pressure fell precipitously. A diagnosis of IAB rupture was made and as IABC was discontinued and the IAB removed, cardiac massage was instituted. The patient was placed head down and pressure, was applied over the carotid arteries. The aortic peffusion cannula was disconnected from its tubing to allow back bleeding and gas evacuation. The venous cannulae were replaced and CPB recommenced. Visual inspection of the lAB ft~llowing removal revealed two holes near its tip and blood in the tubing. Attempts to insert a replacement lAB via left or right femoral arteries were unsuccessful. However, with infusion of dopamine (10 p,g. kg -j . min-1),dobutamine(I 5vg. kg -t 9 rain-t), epinephrine (4 I~g ' tour I) and calcium (1 mg-min-~), it was possible to wean the patient from CPB and close the chest.
The patient was transferred to the Intensive Care Unit where, within one hour, he had a cardiac arrest from which he could not be resuscitated. Consent for autopsy was refused.
Discussion
The most common indication for IABC is to assist in weaning of patients from CPB and to augment cardiac output in post-CPB low output states. 3'4 IABC in this setting is associated with in-hospital survival rates of 60 per cent in patients with coronary artery disease as the preoperative diagnosis. 5 Lower in-hospital and long-term survival rates are seen where valve replacement is the indication for surgery. This is particularly so with IABC post-aortic valve replacement for aortic incompetence where the one year survival is only 13 per cent. 6 Complications associated with IABC may occur in up to 45 per cent of patients. 7 The majority are minor and resolve with removal of the lAB being related to the vascular status of the patient.
Complications can be classified into three categories: those related to in sertion, use, and removal of the balloon. Insertion may be associated with failure to pass the balloon, aortic dissection and/or perforation. When the balloon is in place and operating: llmb ischaemia, local or systemic infection, embolization, balloon rupture and thrombocytopaenia may occur. Following removal hematoma formation or bleeding at the insertion site and femoral artery thrombosis have been described.
Infectious complications are reduced by percutaneous insertion of the IAB, s but this may increase the risk of vascular damage.'* Should vascalar damage occur, early recognition and repair is essential. 9
Balloon rupture is a rare but potentially disastrous complication of IABC. ~9 In this case it was noted immediately by the detection of gas in the aortic line but in other reported cases the hallmark of rupture has been the presence of blood in the balloon tubing and an alteration in the configuration of the balloon pressure curve. I]J2 Damage to the balloon at insertion or during the process of inflation and deflation by atheromatous plaque is thought m cause balloon rupture. The overall incidence of balloon rupture is reported to be 0.12 and 1.3 per cent. ]3
In the case described, rupture appears to have been caused hy the accidental insertion of a needle into the IAB in an attempt to administer protamine into the ascending aorta. This would imply that a part of the LAB was positioned in ascending aorta. In this case one would have expected to have seen an alteration in the left radial waveform, but this did not occur. Indeed, when the surgeon directly measured the pressure in the ascending aorta Io rule out a disparity between the aortic and peripheral arterial pressures,the aortic pressure waveform obtained was virtually identical to the left radial "arterial wavefor'm. Accidental placement of an IAB in the left subclavian artery with a normal left radial pulse after insertion has been reported, t4 Factors thought to encourage cephaiad migration of the IAB include assumption of the sitting position and flexion of the lower limb at the site of lAB insertion. 15 Neither of these factors were present in our case.
The driving gas used in IABC devices can be either helium or carbon dioxide. Helium is less dense than air or carbon dioxide and so provides a faster response time during the process of inflation and deflation. This should theoretically result in a steeper rise and fall in diastolic augmentation pressure with a consequent enhancement of diastolic coronary perfusion. Helium is, however, less soluble in blood than air and presents an added hazard should it enter the circulation. Carbon dioxide is 80 times as soluble as helium and 34 times as soluble as air, diffusing into blood faster than any other gas. 13 For this reason it may be the safest driving gas for IABC. The use helium as the driving gas in our case may have exacerbated the consequences of balloon rupture.
The direct intra-aortic administration of protamine has not been shown to offer any clinical advantage over judicious peripheral intravenous administration ~6'~7 and in particular does not modify the incidence or severity of pulmonary vasoconstriction occasionally seen with the use of protamine.'a We would advise that instrumentation of the aorta in the presence of an IAB be avoided and constant vigilance maintained for the signs of balloon rupture -a potentially fatal event -during IABC therapy.
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